In controlled trials, subjects treated with GLP1-S displayed lower glucose area under the curve (AUC) during standardized meal tests, pointing to coordinated effects on pancreatic, hepatic, and gastrointestinal functions
Weight management/metabolic effects: GLP-1 RAs may also support weight management in adults with type 2 diabetes who are overweight or obese, providing an added metabolic advantage alongside their primary glycaemic and cardioprotective effects
Retrieved from Jouanne, M., Oddoux, S., Nol, A., et al
The GLP-1 Revolution: How Next-Generation Obesity Drugs Are Reshaping Global Healthcare Obesity now affects more than 1 billion people globally, making it one of the most urgent public health and pharmaceutical market opportunities of this decade
Some people experience post-cholecystectomy syndromechronic diarrhea, bloating, and altered nutrient absorptionwhich can complicate weight loss medication tolerability
YOU WANT A LONG-TERM GAME PLAN
